Brain’s Role in High Blood Pressure: A New Target for Treatment
For years, high blood pressure (hypertension) has been primarily linked to issues with the kidneys and blood vessels. However, emerging research from the University of Auckland in New Zealand suggests a surprising culprit: a specific region of the brain. This discovery opens new avenues for understanding and potentially treating this widespread health condition.
The Lateral Parafacial Region: A Key Discovery
Scientists have identified the lateral parafacial region (pFL) in the brainstem as a key regulator of blood pressure. The brainstem, the oldest part of the brain, controls essential automatic functions like breathing, digestion, and heart rate. The pFL is activated during forceful exhalations – such as those experienced during laughter, exercise, or coughing 1.
Professor Julian Paton, director of Manaaki Manawa, Centre for Heart Research at the University of Auckland, explains that normal exhalation relies on the elasticity of the lungs. However, when the pFL is activated, it triggers a “forced” exhalation that involves the contraction of abdominal muscles 1. Researchers found this same area similarly connects to nerves that constrict blood vessels, ultimately raising blood pressure 1.
How the Brain Impacts Blood Pressure
In studies, researchers observed increased activity in the pFL during episodes of high blood pressure. Crucially, when the pFL was inactivated, blood pressure returned to normal levels 1, 2, 3. This suggests a direct link between this brain region and the development of hypertension.
Changes in breathing patterns, particularly those involving strong abdominal muscle contractions, can trigger high blood pressure. This finding suggests that diagnosing abdominal breathing patterns in patients with hypertension could help pinpoint the cause and guide appropriate treatment 1.
A New Approach to Treatment
Whereas directly targeting the brain with medication presents challenges due to the potential for widespread effects, researchers are exploring alternative strategies. They are focusing on the carotid body, a sensory organ near the carotid artery in the neck, which sends signals to activate the pFL 2.
Professor Paton is currently developing a drug strategy to indirectly deactivate the pFL by inhibiting the activity of the carotid body 3. This approach aims to treat high blood pressure more safely, avoiding the risks associated with drugs that directly affect the brain. This could be particularly beneficial for individuals with conditions like sleep apnea, where the carotid body may be overactive 3.
Looking Ahead
This research highlights the importance of considering the brainstem circuit in the development of high blood pressure, alongside traditional factors like kidney and blood vessel health. While further research and clinical trials are needed, this discovery offers a promising new direction for the treatment of hypertension. The findings, recently published in Circulation Research 1, 3, could lead to safer and more effective therapies for millions affected by this condition.
Worth a look